NCT00861029 - VEG111485: A QTc Study of Pazopanib | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 19, 2009

Primary Completion Date

February 15, 2010

Study Completion Date

February 15, 2010

Conditions

Carcinoma, Renal Cell

Interventions

DRUG

Pazopanib

Subjects treated with pazopanib

OTHER

Placebo for pazopanib

Control for comparison with pazopanib

DRUG

Moxifloxacin

Comparator for pazopanib

OTHER

Placebo for moxifloxacin

Trial Locations (8)

GSK Investigational Site, Greenville

GSK Investigational Site, Nashville

GSK Investigational Site, Detroit

GSK Investigational Site, Santa Monica

GSK Investigational Site, Duarte

GSK Investigational Site, Tacoma

GSK Investigational Site, Lebanon

GSK Investigational Site, New Brunswick